Ocular Therapeutix, Inc.
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Job Posting Salary Data
From 1 marketing roles posted in the last 12 months
Community Salary Data
Help build salary transparency at Ocular Therapeutix, Inc.. Share your compensation anonymously.
Reviews
Jobs
About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLITM (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYXTM technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and has potential applications across other retinal diseases such as non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME).
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2006
- Headquarters
- Bedford
Why Work at Ocular Therapeutix, Inc.?
Discover what makes Ocular Therapeutix, Inc. a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
